SYNCHRONIZE-CVOT
👥5,530, excess weight + ⤴️CV risk (CVD, CKD or ⤴️ risk)
⚖️Survodutide vs placebo
📊5-point MACE HR 0.89 (95% CI 0.67–1.18)
⚠️Noninferior; superiority unproven
🔗
#AHA26 #ScientificSessions26 #CVPrev @BiykemB @TheLancet
28201.3K
Posts with #CVPrev
#CVPrev
Public posts on X that use #CVPrev.
Related hashtags
American College of Cardiology@ACCinTouch🆕 ACC Scientific Statement in #JACC: A healthy dietary pattern matters more than any single nutrient or food for heart health. 🫀 🔗 Read more: #cvPrev #ACCPrev @JACCJournals
1621387.8K
JACC Journals@JACCJournalsCan lifting weights + less TV lower heart risk? In a #JACC cohort of 117K women, aerobic exercise ≥15 MET-h/week + lifting ≥1 h/week + TV <2 h/day linked to 40% lower risk of major cardiovascular events. #cvPrev @CeciliaZhangdoc
115414K- JACC Journals@JACCJournalsIt takes a village. A combined medical effort with community and family leadership focused on household diets, home monitoring, exercise, and treatment dropped SBP by > 10 mmHg more than usual care: #JACC #cvPrev #hypertension
13142.8K - JACC Journals@JACCJournalsCan optimizing Life’s Essential 8 improve CV & kidney outcomes in pts w/ established #ASCVD? A large UK Biobank study in #JACCAdvances found lower CV health scores were associated w/ a 2.68-fold higher risk of MACE & 2.34-fold higher risk of CKD. #cvPrev
111344.1K - 💉 CAMEO-SEMA 👥 81 with obesity + HFpEF; 58% women ⚖️ Semaglutide vs placebo 📊 52wk exercise PAWP −10.6 mmHg (95% CI −13.3 to −8.0) ✅ Mechanistic support; small trial 🔗 #AHA26 #ScientificSessions26 #CVPrev
712482.3K - American College of Cardiology@ACCinTouchDrs. Fred M. Kusumoto and Joseph Ebinger break down key prevention takeaways from the REDUCE and OPTIMAL-STROKE trials presented at #ScientificSessions26. Stay on top of the science with ACC’s Meeting Coverage ➡️ #ACCAnywhere #cvPrev #ACCPrev0131.1K
- American College of Cardiology@ACCinTouchIntensive BP-lowering therapy in patients w/ T2D & a yoga-based cardiac rehabilitation program for people w/ #HFrEF were among the hot topics in #cvPrev at today’s #ScientificSessions26. Read on for results from the OPTIMAL-DIABETES & Yoga-CaRe HF trials:
0151.9K - Lower is better! #LDL #CVPrev #Cardiotwitter But also, let’s enroll more women into CV trials please!🙏🏽NEJM @NEJMAmong patients with atherosclerotic cardiovascular disease, targeting an LDL cholesterol level below 55 mg per deciliter led to a lower 3-year risk of cardiovascular events than targeting a level below 70 mg per deciliter. Full Ez-PAVE trial results and Research Summary:101910514.4K
Among patients with atherosclerotic cardiovascular disease, targeting an LDL cholesterol level below 55 mg per deciliter led to a lower 3-year risk of cardiovascular events than targeting a level below 70 mg per deciliter. Full Ez-PAVE trial results and Research Summary:
27236740176K- 🧠 OPTIMAL-Stroke: 4,368 prior ischemic stroke/TIA; 47.9% women, followed for 3.9y 🫀lower 🆚 higher BP: SBP <120 vs <140: MACE 10.9% vs 13.5%; HR 0.79 (95% CI 0.67–0.94) 💥Supports lower target BP #AHA26 #ScientificSessions26 #CVPrev @NEJM
211312.1K - JACC Journals@JACCJournalsDoes a 0 calcium score mean you can skip the statin? This MESA study takes a closer look at how CAC may refine statin decisions in the PREVENT era. #JACC #cvPrev #ASCVD
57721839.9K - Do you check UACR (urine albumin-creatinine ratio)? It is not for just those with known CKD- at that point it's too late! 🚨If you are a cardiologist, most if not all need an annual UACR check 🚨 Risk for CKD: ⤴️ with DM, HTN, ASCVD, HF Obesity... 🫀This is our lane #CVPrev
153615617.3K 
MUST READ - Risk prediction tools in #cvprev A report from ESC Prevention of CVD Programme led by #EAPC_ESC in collaboration with #ESCACCA and #ACNAP #cardiotwitter @m_piepoli @PaulDendale @EkateriniL
26192- American College of Cardiology@ACCinTouchIn a new episode of #ACCCardiaCast, Drs. @AbbateAntonio and @Bweber04 discuss the clinical relevance of hs-CRP. 🎧 Tune in here: #cvLipids #cvPrev
1181.9K - American College of Cardiology@ACCinTouchDr. Fred Kusumoto reflects on evolving science across #cvCAD & structural heart disease from #TCT2026 & looks ahead to the latest advances in #cvPrev at #ScientificSessions26. 🔬 Catch up on the science shaping CV care w/ ACC’s Meeting Coverage ➡️0221.4K
💡 2025 Hypertension Guideline Simplified: 10 Takeaways from the Ciccarone Team. @rblument1 @AaronTroyMD @hopkinsheart #CVprev
Roger Blumenthal @rblument110 prevention takeaways from ‘25 high blood pressure guideline - Excellent summary by @CiccaroneCenter @hopkinsheart ⭐️ 🫀 Fellow @AaronTroyMD & Guideline Writing Group Member & 🏍️ enthusiast Stacey Schott @ChiadiNdumele5328721.2K
Roger Blumenthal@rblument110 prevention takeaways from ‘25 high blood pressure guideline - Excellent summary by @CiccaroneCenter @hopkinsheart ⭐️ 🫀 Fellow @AaronTroyMD & Guideline Writing Group Member & 🏍️ enthusiast Stacey Schott @ChiadiNdumele3165122.8K- Cleaner Air for Lower Cardiometabolic Risk 🌬️ Cleaner Air 👥 150 with prediabetes; 44% women ⚖️ HEPA vs sham filtration 📊 4wk glucose variability −7.7% (95% CI −14.0 to −1.0) ✅ Promising surrogate benefit #AHA26 #ScientificSessions26 #CVPrev
015282K 
There is no place for aspirin in primary #cvprev. Recent trials show no or a very limited benifit VS a higher bleeding risk. Futher subgroup analysis is needed to see if patients with certain #riskfactors could benefit. @monikahollander #EAPC_ESC #ESCCongress
383119- American College of Cardiology@ACCinTouch🔑 Colchicine 0.5 mg daily is FDA-approved for secondary prevention in patients w/ coronary artery disease. Read key points to remember from a state-of-the-art review on the long-term safety of low-dose colchicine for atherosclerosis: #cvPrev114536144.1K
- 🧠 REDUCE: 160 stroke survivors; 38% women Adding spironolactone vs usual care: home significantly ⤵️ SBP ~126 vs 133 mmHg at 3mo ✅ Promising BP strategy ⚠️ Fewer recurrent strokes NOT established ⚠️ 👀 potassium #AHA26 #ScientificSessions26 #CVPrev #Ilovespironolactone
08241.3K - Show more posts
